BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 19227204)

  • 1. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
    Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
    Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on prostatic cancer detected incidentally by transurethral resection of the prostate].
    Hayakawa T; Mitsuya H; Kojima M; Hayase Y
    Hinyokika Kiyo; 2002 Jan; 48(1):13-6. PubMed ID: 11868378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
    Tanaka Y; Aoyama H; Momose H; Ono T; Samma S; Tanaka N; Akiyama T; Tani Y; Masuda Y; Matsuki H; Tani M; Tanaka M
    Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of incidental prostate cancer following TUPVP (a report of 15 cases)].
    Gu X; Zhu Q; Zhang P; Zhang Y; Lu Z; Xu Y; Huang S
    Zhonghua Nan Ke Xue; 2004 Nov; 10(11):849-50, 854. PubMed ID: 15595689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of patients with stage T1b incidental prostate cancer.
    Argyropoulos A; Doumas K; Farmakis A; Aristas O; Kontogeorgos G; Lykourinas M
    Scand J Urol Nephrol; 2005; 39(4):289-93. PubMed ID: 16118104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis in stage a prostate cancer].
    Murase T; Kuriyama M; Maeda S; Ando Y; Itoh H; Watanabe H
    Hinyokika Kiyo; 1996 Sep; 42(9):639-43. PubMed ID: 8918661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidental prostate cancer: volume, location and degree of differentiation of the tumor in the radical prostatectomy specimen and value of subclassification to stage A1 and A2].
    Voges GE; McNeal JE; Stamey TA
    Urologe A; 1991 Nov; 30(6):401-9. PubMed ID: 1722922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
    Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?
    Voigt S; Hüttig F; Koch R; Propping S; Propping C; Grimm MO; Wirth M
    Prostate; 2011 Sep; 71(12):1325-31. PubMed ID: 21308716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of prostatic cancer screening in patients treated for benign prostatic hyperplasia with medical or minimally invasive modalities.
    Orihuela E; Kocurek JN; Warren MM
    Arch Esp Urol; 1997 Sep; 50(7):821-4. PubMed ID: 9350090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of incidentally detected prostate cancer: role of repeat resection, prostate-specific antigen, needle biopsy, and imaging.
    Griebling TL; Williams RD
    Semin Urol Oncol; 1996 Aug; 14(3):156-64. PubMed ID: 8865478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of prostate specific antigen failure after radical prostatectomy for prostate cancer: a single center experience].
    Taue R; Takahashi M; Fukawa T; Koizumi T; Nakanishi R; Yamaguchi K; Yamamoto Y; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Kanayama HO
    Hinyokika Kiyo; 2009 Jan; 55(1):1-4. PubMed ID: 19227203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stage A prostate cancer: comparison of subclassification between Japanese rule and TNM, and outcome].
    Tanaka M; Suzuki N; Nakatsu H; Murakami S; Matsuzaki O; Shimazaki J
    Hinyokika Kiyo; 2003 Oct; 49(10):579-82. PubMed ID: 14655599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
    Bright EA; Manuel C; Goddard JC; Khan MA
    Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of cancer of the prostate. Value of systemic screening and of diagnosis in incidental cancer (stage A)].
    Solé Balcells FJ
    Arch Esp Urol; 1989; 42 Suppl 2():131-8. PubMed ID: 2484149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
    Jones JS; Follis HW; Johnson JR
    Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostatic specific antigen for detection and monitoring of prostatic cancer].
    Gofrit O; Pode D; Gez E; Pfau A; Roizman I; Lifshitz Y; Barak V
    Harefuah; 1992 Mar; 122(6):345-8, 408. PubMed ID: 1374729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.